Responses
ePoster Viewing: Trials-in-Progress
AS04. Endometrial/Uterine corpus cancers
TP008/#1500 Trial in progress: phase 2/3 study of navtemadlin as maintenance therapy in patients with advanced or recurrent endometrial cancer who responded to chemotherapy (ENGOT-EN21; GOG-3089)
Compose a Response to This Article
Other responses
No responses have been published for this article.